During Myositis Awareness Month, May 2018, we placed a large focus on patient education by hosting some of the...
Tag Archive for: dermatomyositis
EULAR/ACR Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups
Myositis Support, , Featured, NewsClinical trials and studies require patient groups in clearly defined categories, but the multiple diagnostic and classification criteria used...
Dermatomyositis Patients with a Certain Type of Autoantibodies at Higher Risk of Skin Eruptions with Use of Hydroxychloroquine
Myositis Support, , Featured, NewsIn this study, the researchers set out to determine if there was a distinction between the type of autoantibodies...
Lenabasum for dermatomyositis receives orphan designation in the European Union
Myositis Support, , NewsToday, Corbus Pharmaceuticals announced that the European Commission has approved orphan designation for lenabasum in the treatment of dermatomyositis...
Corbus Pharmaceuticals announced today that they will proceed with a Phase 3 clinical trial to evaluate the efficacy and...
"New Developments on the Role of Itch in Dermatomyositis", based on new research published in the British Journal of...
Corbus Pharmaceuticals will host Jerry Williams, the Founder and President of MSU, Heather Spadaccini, Jerry’s friend and part-time caregiver,...
Dr. Victoria Werth, MD, presents, "Overview and new developments in Dermatomyositis." This was a live Myositis Support and Understanding...
What I find myself thinking about now, for the first time, in any detail, is who I was at...
A wife, sister, soldier, student, and a daughter. Life was great. 22 years old and nothing seemed impossible. The...
Investigators are seeking people with dermatomyositis to participate in a phase 2 clinical trial of the experimental drug IMO-8400....
Dear Dermatomyositis, I am writing you because I found out in January 2015 you were the culprit behind my...
Over the next few days, I would wake up every other morning with my eyes swollen, to the point I...
Dermatomyositis is a rare autoimmune disease, occurring in only 5-10 people per million, which is caused by the body’s...